Investor Presentaiton

Solid progress on HeyloTM and Luja™; Luja is launched in four markets and is expected to be available in key markets over the next 9 months Status May 2023 31 Luja™M new catheter · platform Heylo™ • Product launched in four markets Expected launch Product launch expected The results of the first pivotal clinical study have been published*. The second study has been finalized and Coloplast expects to publish the results within the next few months in key markets over the next 9 months CE mark has been granted digital leakage notification system Payer pilot studies in Germany and the UK progressing as planned, with good user feedback Product launch expected in 2023 Simultaneously, continue our launch cadence into existing categories within ostomy care and continence care Luja is a medical device for which CE-mark has been affixed. Product availability is subject to regulatory process of individual countries and is not guaranteed. *Study shows significant improvement in bladder emptying with Coloplast LujaTM compared to competitor catheter Coloplast

View entire presentation